의료기기관련기관/국가임상시험지원재단
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 04.14(금)
toucrew
2023. 4. 25. 16:46
반응형
| Global Data Intelligence Center | ||
| 구분 | 보고서 (영문) | 업로드 날짜 |
| 제약/바이오/임상시험 | Q1 Claimed the Highest Number of Trial Starts in 2022 | 03-31-2023 |
| Emerging Market Outsourcing Report – Q1 2023 | 03-31-2023 | |
| Reinforcement for AbbVie’s Skyrizi and Promise for Takeda’s TAK-279 in Plaque Psoriasis at AAD 2023 | 03-31-2023 | |
| Bio/Pharmaceutical Outsourcing Report, March 2023 | 03-31-2023 | |
| Latest WHO COVID-19 Vaccine Guidance May Decrease Future Demand | 03-31-2023 | |
| AD/PD 2023: Lecanemab Quality of Life Data Highlights Value for Patients and Caregivers | 03-31-2023 | |
| AD/PD 2023: Lilly Highlights Potential Durability of Treatment with Donanemab | 03-31-2023 | |
| 질환별 |
Obsessive-Compulsive Disorder (OCD): Competitive Landscape | 03-31-2023 |
| Myelofibrosis: Eight-Market Drug Forecast and Market Analysis | 03-31-2023 | |
| Obesity: 68-Market Analysis and Sales Forecast | 03-31-2023 | |
| Unmet Needs in the Lupus Market | 03-31-2023 | |
| Mucopolysaccharidosis II (MPS II): Competitive Landscape | 03-31-2023 | |
반응형